FenWangMD

Radiation Oncology • Kansas City, KS

Associate Professor, Radiation Oncology, University Kansas School of Medicine

Join to view full profile

Dr. Wang is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
Connect with colleagues in the same hospital or clinic.
Read the latest clinical news, personalized to your specialty.

See Dr. Wang's full profile

Already have an account?

Office
3901 Rainbow Blvd
Mail Stop 4033
Kansas City, KS 66160
Phone+1 913-588-3644

Fax+1 913-588-3663

Education & Training

University of Kansas School of MedicineResidency, Radiation Oncology, 1998 - 2002
USA HealthInternship, Transitional Year, 1997 - 1998
Beijing Medical UniversityClass of 1984

Certifications & Licensure

KS State Medical License 2002 - 2025
MO State Medical License 2015 - 2025
American Board of Radiology Radiation Oncology

Clinical Trials

Radiation Therapy With or Without Androgen-Deprivation Therapy in Treating Patients With Prostate Cancer Start of enrollment: 2009 Sep 01
Active, not recruiting
Phase 3

Publications & Presentations

PubMed

Reirradiation of Utracentrally Located Thoracic Tumors Using a 10-Fraction Hypofractionated Stereotactic Body Radiation Therapy Course: A Detailed Dosimetric Analysis.
Crosby Rock, Katelyn Kane, Sumit Sood, Ying Cao, Ronald C Chen
Advances in Radiation Oncology. 2024-12-01
Proton ARC based LATTICE radiation therapy: feasibility study, energy layer optimization and LET optimization.
Ya-Nan Zhu, Weijie Zhang, Jufri Setianegara, Yuting Lin, Erik Traneus
Physics in Medicine and Biology. 2024-10-25
1 citations
Volume staged stereotactic radiosurgery and endovascular embolization in the treatment of cerebral proliferative angiopathy: lessons learned.
Aaron Brake, Lane Fry, Kevin S Chatley, Jeremy Peterson, Timothy Stepp
British Journal of Neurosurgery. 2024-10-01

Lectures

Aberrant FGFR Tyrosine Kinase Signaling Enhances the Warburg Effect by Reprogramming LDH Isoform Expression and Activity in Prostate Cancer
2019 ASCO Annual Meeting - 6/1/2019

Press Mentions

Identification of the PTEN-arid4b-pi3k Pathway Reveals the Dependency on ARID4B by PTEN-Deficient Prostate CancerSeptember 24th, 2020